Loading...
149 Europe Chronic Disorder Drugs Reports
Country Covered: France
Study Period: 2019 - 2029
Major Players: AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Johnson & Johnson
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: United Kingdom, Germany, France, Russia, Spain, Italy
Major Players: Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Biocon
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Meyrs Squibb Company, F. Hoffmann-La Roche Ltd
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: United Kingdom, Germany, Italy, Spain, France, Russia
Major Players: Eli Lilly, Astrazeneca, Novo Nordisk, Sanofi, Boehringer Ingelheim
Region Covered: Europe
Study Period: 2018 - 2029
Countries Covered: France, Germany, Italy, Russia, Spain, United Kingdom
Major Players: Teva, Bristol-Myers Squibb, AstraZeneca, Sanofi Aventis, Merck and Co.
Country Covered: United Kingdom
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Country Covered: France
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Sanofi Aventis, Novo Nordisk A/S, Eli Lilly and Company
Country Covered: Spain
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, Novo Nordisk
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Germany
Study Period: 2018 - 2029
Major Players: Novo Nordisk A/S, Sanofi Aventis, AstraZeneca, Eli Lilly and Company, Merck
Country Covered: Italy
Study Period: 2018 - 2029
Major Players: Novo Nordisk A/S, AstraZeneca, Boehringer Ingelheim, Sanofi Aventis, Eli Lilly and Company
Country Covered: Italy
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janseen
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: France, Germany, Italy, Russia, Spain, United Kingdom
Major Players: Sanofi, Eli Lilly, Astrazeneca, Astellas, Janseen
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca PLC, Bayer AG, F. Hoffmann La-Roche Ltd, Teva Pharmaceutical Industries Ltd, Seagen Inc
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Merck KGaA, Johnson and Johnson, Pfizer, Inc.
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, SymBio Pharmaceuticals Limited, Genmab AS
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson (Janssen Pharmaceuticals Inc.), Novartis AG, Bristol Myers Squibb Company, Merck & Co. Inc, F. Hoffmann-La Roche Ltd
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol Myers Squibb, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, GlaxoSmithKline (GSK) PLC
Region Covered: Europe
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Otsuka holdings co., ltd., Bristol Myers Squibb
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., AstraZeneca PLC, Hoffmann-La Roche AG, Eli Lilly and Company , GSK plc
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Abbvie, F. Hoffmann-La Roche Ltd
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bausch Health Companies Inc., Novartis AG, AbbVie Inc., Almirall SA
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company
Region Covered: Europe
Study Period: 2020 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Novartis International AG, Sanofi S.A.
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Bayer AG, Pfizer Inc., Novartis International AG, Johnson and Johnson
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG, Amgen Inc.
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol‑Myers Squibb Company, Eisai Co., Ltd., Exelixis Inc, Merck & Co. Inc., Bayer AG
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Baxter International, Inc., GlaxoSmithKline PLC, Pfizer, Inc., Johnson & Johnson, Novartis AG
Region Covered: Europe
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Teva Pharmaceuticals, L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique), Sun Pharmaceutical Industries, Inc., JOHNSON & JOHNSON, Abbvie Inc (Allergan PLC)
Region Covered: Europe
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis AG, Merck Co & Inc., Fresenius Kabi, Pfizer Inc., Eli Lilly & Co.
Filter Reports
By Countries
